Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-29T10:32:33.635Z Has data issue: false hasContentIssue false

P.027 Incidence of amyotrophic lateral sclerosis in Newfoundland and Labrador

Published online by Cambridge University Press:  05 June 2019

KS Aminian
Affiliation:
(Halifax)
G Whelan
Affiliation:
(St. John’s)
D Murphy
Affiliation:
(St. John’s)
M Stefanelli
Affiliation:
(St. John’s)
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Background: There is a paucity of research regarding ALS epidemiology in Canada. Previously published data from Newfoundland and Labrador (NL) demonstrate an average incidence of 2.4/100,000 from 2000-2004 (peak 3.3 in 2001, the highest reported in Canada). Local neurologists believe that the incidence has continued to increase. Methods: Clinicians affiliated with the electromyography (EMG) lab at the Health Sciences Centre in St. John’s compiled a list of patients diagnosed with ALS from 2012-2016, based on recall. Their medical records were reviewed and demographic information collected. This was cross-referenced with new referrals to the ALS Society NL per year. Results: Based on new referrals to ALS Society NL the average incidence between 2012-2016 was 2.81/100,000 (peak 3.6 in 2015). Average age-adjusted incidence from the EMG lab was 1.33 (peak 1.73 in 2016). The EMG lab documented a crude incidence of 3.97 in 2018. Conclusions: The incidence of ALS in NL is increased compared to the usual incidence of 1-2/100,000 per year. After the preliminary study, the EMG lab maintained more thorough records and an incidence of 3.97/100,000 was found in 2018. This makes a compelling argument for future research which could explore potential genetic or environmental causes for the increased incidence in this population.

Type
Poster Presentations
Copyright
© The Canadian Journal of Neurological Sciences Inc. 2019